Paul Hartmann AG
F:PHH2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Paul Hartmann AG
Note Receivable
Paul Hartmann AG
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Paul Hartmann AG
F:PHH2
|
Note Receivable
€7.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
Paul Hartmann AG
Glance View
Paul Hartmann AG engages in the production of medical and hygiene products. The company is headquartered in Heidenheim, Bayern and currently employs 10,628 full-time employees. The company went IPO on 2003-01-01. The firm operates through four segments, namely Wound Management, Incontinence Management, Infection Management and Other Group Activities. The Wound Management segment comprises wound dressings, as well as products for compression treatment, immobilization, First Aid and diagnostic devices. The Incontinence Management segment includes absorbent products worn close to the body for incontinence hygiene, such as under pads for patients as well as patient hygiene products and medical skin care. The Infection Management segment covers a range of custom procedure trays, surgical draping systems, surgical clothing, and surgical and examination gloves as well as the disinfection assortment. The Other Group Activities includes activities in cotton-wool products, feminine hygiene, baby care, medical consumer goods and pharmaceutical products, among others.
See Also
What is Paul Hartmann AG's Note Receivable?
Note Receivable
7.7m
EUR
Based on the financial report for Dec 31, 2024, Paul Hartmann AG's Note Receivable amounts to 7.7m EUR.
What is Paul Hartmann AG's Note Receivable growth rate?
Note Receivable CAGR 10Y
5%
Over the last year, the Note Receivable growth was 18%. The average annual Note Receivable growth rates for Paul Hartmann AG have been 8% over the past three years , -1% over the past five years , and 5% over the past ten years .
